A matched-pair, randomized study evaluating the efficacy and safety of acticoat silver-coated dressing for the treatment of burn wounds

Journal of Burn Care and Rehabilitation

Volumn 19, Issue 6, 1998, Pages 531-537

  Tredget, Edward E ^a   Shankowsky, Heather A ^b   Groeneveld, Audrey ^c   Burrell, Robert ^b  

^a University of Alberta Hospital ^*

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c Westaim Biomedical Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BURN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTAMINATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITAL INFECTION; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; SILVER IMPREGNATION; SKIN BIOPSY; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

EID: 0031769299     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-199811000-00013     Document Type: Article

References (39)

1. Pruitt BA, McManus AT. The changing epidemiology of infections in burn patients. World J Surg 1992;16:57-67.
2. Kaye ET, Kaye KM. Topical antibacterial agents. Infect Dis Clin North Am 1995;9:547-59.
3. Ward RS, Saffle JR. Topical agents in burn and wound care. Phys Ther 1995;75:526-38.
4. Monafo WW, Ayvazian VH. Topical therapy. Surg Clin North Am 1978;58:1157-71.
5. Shankowsky HA, Callioux LS, Tredget EE. North American survey of hydrotherapy in modern burn care. J Burn Care Rehabil 1994;15:143-6.
6. Thomson PD, Bowden ML, McDonald K, et al. A survey of burn hydrotherapy in the United States. J Burn Care Rehabil 1990;ll:151-5.
7. Tredget EE, Shankowsky HA, JofTe AM, Inkson TI, Volpel K, Paranchych W, et al. Epidemiology of infections with Pseitdomonas acntginosa in burn patients: the role of hydrotherapy. Clin Infect Dis 1992;15:941-9.
8. Richard P, Le Floch R, Chamoux C, Pannier M, Espaze E, Riebet H. Pscitdomonas aentginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 1994;170:377-88.
9. Mayhall CG, Lamb VA, Gayle WE, Haynes BW. Enterobacter cloacae septicemia in a burn center: epidemiology and control of an outbreak. J Infect Dis 1979;139:166-71.
10. Roscnquist MD, Kealey GP. Water-borne sources of burn wound contamination by Xtintboinonns (Pscitdomonns) maltophilia and Acinctobacter. Proceed Am Burn Assoc 1992;24:A177.
11. Devia A, Morris S, Saffle J, Davis B, Brinton B, Woods M. An epidemic of mutiply-resistant Acinetobacter in a burn center. Proceed Am Burn Assoc 1996;28:A141.
12. Sheridan RL, Petera L, Lydon M, Salvo PM. Once-daily wound cleansing and dressing change: efficacy and cost. J Burn Care Rehabil 1997;18:139-40.
13. Burrell RE. The in vitro and in vivo antimicrobial potency of a new silver coated dressing for wound care. 510K K955453; Washington DC: 1997.
14. Winter GD, Scales JT. The effect of air drying and dressings on the surface of a wound. Nature 1963;197:91-2.
15. Tredget EE, Shankowsky HA, Taerum TV, Moysa GL, Alton JDM. The role of inhalation injury in burn trauma: a Canadian experience. Ann Surg 1990;212:720-7.
16. Loebl EC, Marvin JA, Heck EL, Curreri PW, Baxter CR. The method of quantitative burn-wound biopsy cultures and its routine use in the care of the burned patient. Am J Clin Pathol 1974;61:20-4.
17. Marvin JA, Muller MJ, Balkeney PE, Meyer WJ III. Pain réponse and pain control. In: Herdon DN, editor. Total burn care. Philadelphia: Saunders; 1996. p. 529-43.
18. Pruitt BA Jr, McManus AT. Opportunistic infections in severely burned patients. Am J Med 1984;76:146-54.
19. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. J Infect 1988;16:128-40.
20. Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem 1994;31:351-70.
21. Mover CA, Brentano L, Cravens DL, Margraf H, Monafo W. Treatment of large human burns with 0.5% silver nitrate solution. Arch Surg 1965;90:812-66.
22. Fox CL. Silver sulfadiazinc, a new topical therapy for Pseudomonas in burns. Arch Surg 1968;96:184-8.
23. McManus AT, Mason AD, McManus WF, Pruitt BA. Twenty-five year review of Pseudomonas aeruginosn bacteremia in a burn center. Eur J Clin Microbiol Infect Dis 1985;4:219-23.
24. Farmer JJ, Weinstein RA, Zierdt CH, Brokopps CD. Hospital outbreaks caused by Fsetidomonas aeniginosa: importance of serogroup Oil. J Clin Microbiol 1982;16:266-70.
25. Heggers J, Linares HA, Edgar P, Villarreal C, Herndon DN. Treatment of infections in burns. In: Herdon DN, editor. Total burn care. Philadelphia: Saunders; 1996. p. 98-135.
26. Walker JL, Mason AD Jr. A standard animal burn. J Trauma 1968;8:1049-51.
27. Ballin JC. Evaluation of a new topical agent for burn therapy: silver sulfadiazine. JAMA 1984;230:1184-5.
28. Greenhalgh D, Rieman M, Neuman B, Fowler L, James LE, Kagan RJ, et al. A comparison of 5% sulfamyulon solution with double antibiotic solution for skin grafts in burns [abstract]. Proc Am Burn Assoc 1997;18:A67.
29. McManus AT, Kim SH, McManus WF, Mason AD, Pruitt BA. Comparison of quantitative microbiology and histopathology in divided burn-wound biopsy specimens. Arch Surg 1987;122:74-6.
30. Buchanan K, Heimbach DM, Minshew BH, Coyle MB. Comparison of quantitative and semiquantitative culture techniques for burn biopsy. J Clin Microbiol 1986;23:258-61.
31. Steer JA, Papini RPG, Wilson APR, McGrouthcr DA, Parkhouse N. Quantitative microbiology in the management of burn patients. Burns 1996;22:173-6.
32. Precht RJ, Burrell RE. A comparative analysis of the antimicrobial efficacy of a novel silver coated dressing, silver sulfadiazine and silver nitrate. J Burn Care Rehabil 1997;18:S178.
33. Deitch EA, Marino AA, Gillespie TE, Albright JA. Silvernylon: a new antimicrobial agent. Antimicrob Agents Chemothcr 1983;23:356-9.
34. Slawson RM, Van Dyke MI, Lee H, Trevors JT. Germanium and silver resistance, accumulation, and toxicity in microorganisms. Plasmid 1992;27:72-9.
35. Wan AT, Conyers RAJ, Coombs CJ, Masterton JP. Determination of silver in blood, urine and tissues of volunteers and burn patients. Clin Chem 1991;37:1683-7.
36. Boosalis MG, McCall JT, Ahrenholz DH, Solem LD, McClain CJ. Serum and urinary silver levels in thermal injury patients. Surgery 1987;101:40-3.
37. Iwasaki S, Yoshimura A, Idcura T, Koshikawa S, Sudo M. Elimination study of silver in a hemodialyzed burn patient treated with silver sulfadiazine cream. Am J Kidney Dis 1997;30:287-90.
38. + and are deficient in porins. J Bacteriol 1997;179:6127-32.
39. Bridges K, Kidson A, Lowbury EJL, Wilkins MD. Gentamicin- and silver-resistant Pseudomonas in a burn unit. BMJ 1979;8:446-9.